IQ U.S. Mid Cap R&D Leaders ETF (MRND) Stock Analysis
DELISTED 2023
What happened to IQ U.S. Mid Cap R&D Leaders ETF (MRND) stock?
IQ U.S. Mid Cap R&D Leaders ETF (MRND) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
IQ U.S. Mid Cap R&D Leaders ETF (MRND) trades at $22.99. IQ U. S. Mid Cap R&D Leaders ETF (MRND) aims to provide exposure to innovative U. Market cap: $4.40M, Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for MRND: MRND does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MRND against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
MRND: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →IQ U.S. Mid Cap R&D Leaders ETF (MRND) Financial Services Profile
IQ U.S. Mid Cap R&D Leaders ETF (MRND) offers investors targeted exposure to U.S. mid-cap companies demonstrating a commitment to innovation through significant research and development (R&D) investments, operating within the competitive asset management landscape and focusing on a specific investment strategy.
What Is the Investment Thesis for MRND?
MRND provides targeted exposure to U.S. mid-cap companies prioritizing R&D, potentially capturing innovation-driven growth. However, its non-diversified nature concentrates risk. The fund's performance hinges on the R&D investments of its holdings translating into tangible financial results. Investors may want to evaluate the fund's expense ratio and trading volume when evaluating its suitability. Growth catalysts include increased investor interest in innovation and technological advancements. A key risk is the potential for R&D investments not yielding expected returns, impacting company performance and the fund's overall value.
Based on FMP financials and quantitative analysis
MRND Key Highlights
MRND focuses on U.S. mid-cap companies with high R&D spending, offering targeted exposure to innovation.
- The fund is non-diversified, concentrating investments for potentially higher returns but also increased risk.
- MRND invests at least 80% of its net assets in the investments included in its underlying index, closely tracking its target benchmark.
- The fund's performance is tied to the success of R&D investments made by its underlying holdings.
- MRND operates within the asset management industry, providing a specialized investment strategy focused on innovation.
Who Are MRND's Competitors?
MRND is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IDKFF ThreeD Capital Inc. | $0.07 | +13.85% | $6.98M | 70 |
| ALTEX Firsthand Alternative Energy Fund | $12.93 | -1.90% | $8.98M | 82 |
| ALISR Calisa Acquisition Corp Right | $0.64 | +0.00% | 79 | |
| BCG Binah Capital Group, Inc. | $1.40 | +0.72% | $23.5M | 78 |
| EEA The European Equity Fund, Inc. | $11.15 | -0.59% | $74.7M | 67 |
| HNNA Hennessy Advisors, Inc. | $9.89 | -1.30% | $78.2M | 81 |
| ETHT ProShares - Ultra Ether ETF | $12.57 | +19.94% | $92.2M | 68 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.62 | -0.18% | $127M | 70 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MRND's Key Strengths?
Targeted exposure to innovation-driven companies.
- Transparent and rules-based investment strategy.
- Potential for high growth due to R&D focus.
What Are MRND's Weaknesses?
Non-diversified nature increases risk.
- Performance is highly dependent on R&D success.
- Vulnerable to market fluctuations in the mid-cap segment.
What Could Drive MRND Stock Higher?
Positive results from R&D investments by underlying holdings.
- Increased investor demand for innovation-focused ETFs.
- Expansion of the underlying index to include more R&D metrics.
What Are the Key Risks for MRND?
R&D investments not yielding expected returns.
- Market downturn impacting mid-cap companies.
- Competition from other ETFs with similar strategies.
What Are the Growth Opportunities for MRND?
- Increased investor interest in innovation and technology could drive demand for MRND. As technological advancements continue to shape various industries, investors may seek exposure to companies at the forefront of innovation. MRND's focus on R&D-intensive mid-cap companies positions it to capitalize on this trend. The growing awareness of the importance of innovation in driving long-term growth could lead to increased inflows into the fund, potentially boosting its assets under management and overall performance.
- Expansion of the underlying index to include a broader range of R&D metrics could enhance MRND's investment strategy. By incorporating additional factors that assess a company's commitment to innovation, the index could identify promising investment opportunities that might be overlooked by traditional R&D spending metrics. This could involve analyzing the quality of R&D, the effectiveness of innovation processes, and the potential for commercializing new technologies. A more comprehensive index could improve the fund's ability to select high-potential companies and generate attractive returns.
- Strategic partnerships with research institutions or technology incubators could provide MRND with access to valuable insights and investment opportunities. Collaborating with organizations that are actively involved in cutting-edge research and development could give the fund a competitive edge in identifying promising companies and technologies. These partnerships could also facilitate due diligence, provide access to expert knowledge, and enhance the fund's understanding of emerging trends in the innovation landscape. By leveraging external expertise, MRND could improve its investment selection process and generate superior returns for its investors.
- Development of educational resources and marketing campaigns to highlight the importance of R&D in driving long-term growth could attract new investors to MRND. Many investors may not fully appreciate the connection between R&D spending and future company performance. By creating informative content that explains the benefits of investing in innovation, MRND could educate potential investors and increase their interest in the fund. These resources could include white papers, webinars, blog posts, and social media campaigns that showcase the impact of R&D on company growth and shareholder value.
- The increasing adoption of thematic investing, focusing on specific trends like innovation, could benefit MRND. Thematic investing has gained popularity as investors seek to align their portfolios with their values and beliefs. As more investors embrace thematic strategies, MRND's focus on R&D-intensive companies could make it a noteworthy option. The fund's investment mandate aligns with the growing interest in investing in companies that are shaping the future through innovation and technological advancements. This trend could lead to increased demand for MRND and drive its growth in the years to come.
What Threats Does MRND Face?
- Competition from other ETFs with similar strategies.
- Economic downturn impacting R&D spending.
- Regulatory changes affecting the asset management industry.
What Are MRND's Competitive Advantages?
- First-mover advantage in offering a focused R&D investment strategy.
- Established track record in tracking the performance of innovation-driven companies.
- Brand recognition within the ETF market.
What Does MRND Do?
IQ U.S. Mid Cap R&D Leaders ETF (MRND) is designed to track the performance of U.S. mid-cap companies that exhibit high levels of research and development (R&D) spending. The fund falls under the asset management industry, providing investors with a focused approach to investing in innovation-driven companies. MRND's strategy centers around identifying and investing in companies that are committed to innovation through R&D. The ETF is non-diversified, meaning it concentrates its investments in a smaller number of holdings compared to diversified funds. This approach allows for potentially higher returns but also carries increased risk. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index. This ensures that the fund closely mirrors the performance of its target index. MRND's investment objective is to provide investors with exposure to companies that are actively investing in their future through R&D, potentially leading to long-term growth and value creation.
What Products and Services Does MRND Offer?
- Tracks the performance of U.S. mid-cap companies with high R&D spending.
- Provides investors with exposure to innovation-driven companies.
- Invests at least 80% of its net assets in its underlying index.
- Offers a non-diversified investment approach.
- Operates within the asset management industry.
- Aims to capture long-term growth potential through R&D investments.
How Does MRND Make Money?
- Generates revenue through management fees charged to investors.
- Fees are calculated as a percentage of the fund's assets under management (AUM).
- AUM growth is driven by investor inflows and the performance of the underlying holdings.
What Industry Does MRND Operate In?
MRND operates within the asset management industry, specifically focusing on ETFs. The ETF market has seen substantial growth, driven by increasing investor demand for low-cost, passively managed investment vehicles. MRND differentiates itself by targeting companies with high R&D spending, tapping into the innovation trend. Competitors like DSOC, IVEG, KBUY, KESG, and MTVR offer alternative investment strategies within the broader ETF landscape. The fund's success depends on its ability to attract investors seeking exposure to innovation-driven mid-cap companies.
Who Are MRND's Key Customers?
- Individual investors seeking exposure to innovation.
- Institutional investors looking for targeted R&D investments.
- Financial advisors seeking specialized investment strategies.
MRND Valuation & Market Position
With a $4.40M market cap, IQ U.S. Mid Cap R&D Leaders ETF sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for IQ U.S. Mid Cap R&D Leaders ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. MRND trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
MRND Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying activity suggests confidence in the ETF's future performance, indicating that those closest to the company see potential upside.
- Community sentiment has shifted positively as discussions around mid-cap growth opportunities have gained traction, reflecting optimism.
- Market perception of mid-cap stocks has improved, driven by recent economic indicators suggesting a recovery in this segment.
- Analysts highlight the ETF's diversified holdings, which may mitigate risks and enhance long-term growth prospects.
Bear Case
- Concerns over rising interest rates could dampen enthusiasm for mid-cap stocks, as borrowing costs may impact growth potential.
- Social sentiment remains mixed, with some investors expressing caution about the volatility typically associated with mid-cap investments.
- Recent market developments have raised questions about the sustainability of the current economic recovery, affecting overall investor confidence.
- Some community discussions indicate skepticism about the ETF's ability to outperform larger-cap indices amid market uncertainty.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MRND Latest News
No recent news available for MRND.
IQ U.S. Mid Cap R&D Leaders ETF Financial Services Stock: Key Questions Answered
What happened to IQ U.S. Mid Cap R&D Leaders ETF (MRND) stock?
IQ U.S. Mid Cap R&D Leaders ETF (MRND) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.
Can I still buy MRND shares?
No. MRND stopped trading on public markets in December 2023, so the shares are not available through a broker. Anything you see quoted for MRND elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MRND stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to IQ U.S. Mid Cap R&D Leaders ETF. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does IQ U.S. Mid Cap R&D Leaders ETF do?
IQ U.S. Mid Cap R&D Leaders ETF (MRND) provides investors with targeted exposure to U.S. mid-cap companies that demonstrate a strong commitment to innovation through high research and development (R&D) spending. The fund operates by tracking an underlying index composed of these companies, investing at least 80% of its net assets in the index's constituents.
What are the main risks for MRND?
The main risks for MRND stem from its non-diversified nature and focus on R&D-intensive companies. A significant risk is the potential for R&D investments not yielding expected returns, which could negatively impact the performance of the underlying holdings and the fund's overall value. Market downturns, particularly in the mid-cap segment, could also adversely affect the fund.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for MRND, limiting the depth of available insights.
- The fund's performance is subject to market fluctuations and the success of R&D investments.